community-associated methicillin-resistant Staphylococcus aureus, community-associated MRSA, CA-MRSA, SCC mec IV, staphylococcal cassette chromosome, Panton-Valentine leucocidin, MRSA, disk diffusion test, clindamycin, daptomycin, trimethoprim-sulfamethoxazole Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial pathogen responsible for a variety of infections in both children and adults. Treatment of infections caused by this organism is problematic due to its resistance to many drugs. Recent reports of community-associated MRSA (CA-MRSA) infections in patients with no known risk factors have serious public health implications. Therapeutic options for these infections are untested; therefore, the potential exists for high morbidity and mortality. Recently, clinical definitions have been established, and new molecular approaches have allowed investigators to distinguish CA-MRSA more easily from traditional nosocomial-derived MRSA strains. Identifying potential risk factors for CA-MRSA acquisition and fully characterizing the epidemiologic, clinical, and molecular properties of these strains are necessary to provide effective therapeutic guidelines. Author(s): Michael J. Rybak, Pharm.D. 1 | Kerry L. LaPlante, Pharm.D. 2 1. Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, and the School of Medicine, Wayne State University, the Detroit Receiving Hospital and University Health Center, Detroit, Michigan. 2. Department of Pharmacy Practice, University of Rhode Island, Kingston, Rhode Island. 2.  | Usefulness of Multiple-Locus VNTR Fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates. Agnieszka Luczak-Kadlubowska, Artur Sabat, Arjana Tambic-Andrasevic, Marina Payerl-Pal, Jolanta Krzyszton-Russjan, Waleria Hryniewicz. Antonie van Leeuwenhoek | Volume: 94 | Issue: 4 | Pps: 543-553 CrossRef |
3.  | Epidural Abscess Due to Spinal Cord Stimulator Trial. Jacob J. Rauchwerger, Gregg H. Zoarski, Romanth Waghmarae, Ronald P. Rabinowitz, Joel L. Kent, Enslin F. Aldrich, Carey Walter F. Closson. Pain Practice | Volume: 8 | Issue: 4 | Pps: 324-328 CrossRef |
4.  | A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Rachel J. Gorwitz. The Pediatric Infectious Disease Journal | Volume: 27 | Issue: 1 | Pps: 1-7 CrossRef |
5.  | Methicillin-resistant Staphylococcus aureus: From the hospital to the community. Armando Paez, Daniel Skiest. Current Infectious Disease Reports | Volume: 10 | Issue: 1 | Pps: 14 CrossRef |
7.  | Community-Acquired Methicillin-Resistant Staphylococcus Aureus Skin Infections. Philip R Cohen. American Journal of Clinical Dermatology | Volume: 8 | Issue: 5 | Pps: 259-270 CrossRef |
8.  | Antimicrobial Susceptibility and Staphylococcal Chromosomal Cassette mec Type in Community- and Hospital-Associated Methicillin-Resistant Staphylococcus aureus. Kerry L. LaPlante, Michael J. Rybak, Muhammad Amjad, Glenn W. Kaatz. Pharmacotherapy | Volume: 27 | Issue: 1 | Pps: 3-10 View Header/Abstract
| View References
| View PDF article (96 KB) |
9.  | Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes • . Benjamin A. Lipsky, John A. Weigelt, Vikas Gupta, Aaron Killian, Michael M. Peng. Infection Control and Hospital Epidemiology | Volume: 28 | Issue: 11 | Pps: 1290 CrossRef |
11.  | MRSA – what is it, and how do we deal with the problem?. John F Barrett. Expert Opinion on Therapeutic Targets | Volume: 9 | Issue: 2 | Pps: 253-265 CrossRef |
|